La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

3D Systems Gestion

Gestion contrôle des critères 2/4

Le PDG 3D Systems' est Jeff Graves, nommé en May2020, a un mandat de 4.25 ans. La rémunération annuelle totale est $ 6.54M, composée du salaire de 13% et des bonus 87%, y compris les actions et options de la société. détient directement 0.59% des actions de la société, d'une valeur de CHF 1.74M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 1.7 ans et 7.2 ans.

Informations clés

Jeff Graves

Directeur général

US$6.5m

Rémunération totale

Pourcentage du salaire du PDG	13.0%
Durée du mandat du directeur général	4.3yrs
Propriété du PDG	0.8%
Durée moyenne d'occupation des postes de direction	2.4yrs
Durée moyenne du mandat des membres du conseil d'administration	7.3yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Jeff Graves a-t-elle évolué par rapport aux bénéfices de 3D Systems?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	-US$348m
Mar 31 2024	n/a	n/a	-US$350m
Dec 31 2023	US$7m	US$850k	-US$363m
Sep 30 2023	n/a	n/a	-US$96m
Jun 30 2023	n/a	n/a	-US$122m
Mar 31 2023	n/a	n/a	-US$126m
Dec 31 2022	US$6m	US$850k	-US$123m
Sep 30 2022	n/a	n/a	-US$104m
Jun 30 2022	n/a	n/a	US$227m
Mar 31 2022	n/a	n/a	US$250m
Dec 31 2021	US$9m	US$837k	US$322m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	n/a	n/a	-US$85m
Dec 31 2020	US$6m	US$489k	-US$150m

Rémunération vs marché: La rémunération totale de Jeff ($USD 6.54M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Swiss ($USD 1.24M ).

Rémunération et revenus: La rémunération de Jeff a augmenté alors que l'entreprise n'est pas rentable.

PDG

Jeff Graves (63 yo)

4.3yrs

Titularisation

US$6,535,630

Compensation

Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Jeffrey Graves	President	4.3yrs	US$6.54m	0.77% $ 2.5m
Reji Puthenveetil	Executive Vice President of Industrial Solutions	4.2yrs	US$2.31m	0.27% $ 890.2k
Jeffrey Creech	Executive VP	less than a year	US$845.99k	0.13% $ 430.9k
Phyllis Nordstrom	Executive VP	3.1yrs	US$2.10m	0.12% $ 400.3k
Charles Hull	Co-Founder	no data	pas de données	0.43% $ 1.4m
Joseph Zuiker	Executive Vice President of Engineering & Operations	1.8yrs	pas de données	0.11% $ 368.7k
Michael McCloskey	Treasurer & VP of Investor Relations	no data	pas de données	pas de données
Harriss Currie	President - Regenerative Medicine	less than a year	pas de données	0.096% $ 311.5k

2.4yrs

Durée moyenne de l'emploi

60.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de DDD est considérée comme expérimentée (ancienneté moyenne 2.4 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Jeffrey Graves	President	4.7yrs	US$6.54m	0.77% $ 2.5m
Charles Hull	Co-Founder	no data	pas de données	0.43% $ 1.4m
Jim Kever	Independent Director	28.7yrs	US$220.00k	0.36% $ 1.2m
Thomas Erickson	Independent Director	8.8yrs	US$228.76k	0.24% $ 778.4k
Kevin Moore	Independent Director	24.9yrs	US$245.00k	0.18% $ 589.5k
Charles McClure	Independent Chairman of the Board	7.5yrs	US$400.00k	0.11% $ 371.8k
William Curran	Independent Director	16.7yrs	US$255.00k	0.11% $ 346.2k
John Tracy	Independent Director	7.3yrs	US$240.00k	0.11% $ 368.4k
Stephen Klasko	Chair of Medical Advisory Board	2.3yrs	pas de données	pas de données
Malissia Clinton	Independent Director	5.5yrs	US$240.00k	0.094% $ 305.8k
Vasant Padmanabhan	Independent Director	3.8yrs	US$216.24k	0.088% $ 287.0k
Claudia Drayton	Independent Director	2.8yrs	US$218.11k	0.075% $ 241.9k

7.3yrs

Durée moyenne de l'emploi

70yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de DDD sont considérés comme expérimentés (ancienneté moyenne 7.2 ans).

3D Systems Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought CHF202k worth of stock

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

Recent updates

3D Systems Corporation(NYSE:DDD) dropped from S&P 600 Industrials (Sector)

3D Systems Expands High Precision Investment Casting Portfolio with QuickCast Air

3D Systems Corporation Updates Earnings Guidance for the Full-Year 2024

3D Systems Corporation to Report Q1, 2024 Results on Aug 19, 2024

3D Systems Corporation to Report First Half, 2024 Results on Aug 26, 2024

3D Systems Corporation announced delayed 10-Q filing

3D Systems Introduces Ext 800 Titan Pellet - Expanding Accessibility of Industrial Extrusion Platform

3D Systems Corporation announced delayed 10-Q filing

3D Systems Announces FDA Clearance for 3D-Printed Pek Cranial Implants

3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing

3D Systems Corporation announced delayed annual 10-K filing

New minor risk - Profitability

3D Systems Corporation Provides Earnings Guidance for the Full-Year of 2024

Full year 2023 earnings released: US$2.85 loss per share (vs US$0.96 loss in FY 2022)

3D Systems Corporation Reports Unaudited Consolidated Impairment Charges Results for the Fourth Quarter Ended December 31, 2023

3D Systems Introduces First Multi-Material, One-Piece Jetted Denture Solution

3D Systems Corporation to Report Q4, 2023 Results on Feb 27, 2024

3D Systems Corporation Announces Executive Changes

3D Systems Corporation Appoints Andrew Johnson as Interim Chief Financial Officer

3D Systems Appoints Jeffrey Creech as Chief Financial Officer

Independent Director recently bought CHF202k worth of stock

Third quarter 2023 earnings released: US$0.09 loss per share (vs US$0.30 loss in 3Q 2022)

3D Systems Corporation to Report Q3, 2023 Results on Nov 08, 2023

Systems Corporation Appoints Margaret E. Wicklund as Senior Vice President and Chief Accounting Officer

3D Systems Corporation Announces CFO Changes

the Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of 3D Systems Corporation Publicly-Traded Common Stock

3D Systems Corporation Revises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: US$0.22 loss per share (vs US$0.26 loss in 2Q 2022)

3D Systems Corporation to Report Q2, 2023 Results on Aug 09, 2023

3D Systems Introduces New Materials Engineered to Expand Capabilities of SLA and Figure 4 Platforms

New minor risk - Shareholder dilution

Insider recently sold CHF135k worth of stock

3D Systems Corporation (NYSE:DDD) submitted a non-binding proposal to acquire Stratasys Ltd. (NasdaqGS:SSYS) for $1.3 billion.

Independent Director recently sold CHF67k worth of stock

3D Systems Corporation Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: US$0.23 loss per share (vs US$0.21 loss in 1Q 2022)

Full year 2022 earnings released: US$0.96 loss per share (vs US$2.62 profit in FY 2021)

3D Systems Introduces ProJet MJP 2500W Plus — New 3D Printing Solution for Jewelry Manufacturing Dramatically Improves Productivity

3D Systems Appoints Dr. Rebekah Gee as Member of Its Medical Advisory Board, Effective March 1, 2023

3D Systems Corporation to Report Q4, 2022 Results on Feb 28, 2023

rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

3D Systems Appoints Bert Bruce to its Medical Advisory Board

Executive VP recently sold CHF68k worth of stock

3D Systems Announces Management Appointments

President recently bought CHF182k worth of stock

High number of new directors

3D Systems Corporation Revises Earnings Guidance for the Fiscal Year 2022

3D Systems Corporation to Report Q3, 2022 Results on Nov 08, 2022

3D Systems Corporation Announces Appointment of Andrew Johnson as Chief Corporate Development Officer

Executive VP recently sold CHF65k worth of stock

3D Systems Corporation Appoints Taci Pereira as Systemic Bio’s Chief Executive Officer

3D Systems Announces First to Market Cuni (Cuni30) Alloy for Laser Powder Bed Fusion

3D Systems Corporation Announces Executive Changes

3D Systems Announces Board Changes

Second quarter 2022 earnings released: US$0.26 loss per share (vs US$0.079 loss in 2Q 2021)

3D Systems Corporation (NYSE:DDD) agreed to acquire dp polar GmbH from Hans Mathea.

3D Systems Announces Appointment of the Honorable Alex M. Azar II to Its Medical Advisory Board

3D Systems Appoints Michael Turner as Executive Vice President, Effective August 29, 2022

High number of new directors

3D Systems Corporation to Report Q2, 2022 Results on Aug 08, 2022

High number of new directors

Co-Founder recently sold CHF282k worth of stock

3D Systems Corporation Announces Appointment of David J. Shulkin to Medical Advisory Board

President recently bought CHF103k worth of stock

3D Systems Announces Establishment of Medical Advisory Board & Appointment of Stephen K. Klasko as Chair

First quarter 2022 earnings released: US$0.21 loss per share (vs US$0.37 profit in 1Q 2021)

3D Systems Corporation Revises Earnings Guidance for the Full Year 2022

3D Systems Announces Revenue Guidance for 2022

3D Systems Corporation Announces Vsp® Bolus to Optimize Radiotherapy Targeting, Improve Patient Experience